Impact of angiotensin receptor–neprilysin inhibition on vascular function in heart failure with reduced ejection fraction: A pilot study

The mechanisms for the benefits of Angiotensin Receptor Neprilysin Inhibition (ARNi) in heart failure patients with reduced ejection fraction (HFrEF) are likely beyond blood pressure reduction. Measures of vascular function such as arterial stiffness and endothelial function are strong prognostic ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Nathaniel, Sangeetha, McGinty, Shane, Witman, Melissa A. H., Edwards, David G., Farquhar, William B., Hosmane, Vinay, Wenner, Megan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897740/
https://www.ncbi.nlm.nih.gov/pubmed/35246960
http://dx.doi.org/10.14814/phy2.15209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897740/
https://www.ncbi.nlm.nih.gov/pubmed/35246960
http://dx.doi.org/10.14814/phy2.15209

Ejemplares similares